TSS
BMRN icon

Two Sigma Securities’s BioMarin Pharmaceuticals BMRN Stock Holding History

Two Sigma Securities’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25M Buy
+22,096
New +$1.29M 0.15% 166
2025
Q3 		– Sell
-29,512
Closed -$1.62M – 1424
2025
Q2 		$1.62M Buy
+29,512
New +$1.74M 0.2% 112
2025
Q1 		– Sell
-3,284
Closed -$216K – 1500
2024
Q4 		$216K Sell
3,284
-100,143
-97% -$6.71M 0.03% 927
2024
Q3 		$7.27M Buy
103,427
+74,598
+259% +$6.24M 0.12% 203
2024
Q2 		$2.37M Sell
28,829
-8,843
-23% -$736K 0.03% 643
2024
Q1 		$3.29M Buy
37,672
+17,364
+86% +$1.55M 0.03% 538
2023
Q4 		$1.96M Buy
20,308
+12,552
+162% +$1.11M 0.02% 705
2023
Q3 		$686K Sell
7,756
-3,971
-34% -$353K 0.01% 1289
2023
Q2 		$1.02M Buy
+11,727
New +$1.1M 0.02% 954
2022
Q3 		– Sell
-8,803
Closed -$730K – 2617
2022
Q2 		$730K Buy
+8,803
New +$701K 0.03% 688
2021
Q3 		– Sell
-3,350
Closed -$280K – 1567
2021
Q2 		$280K Buy
+3,350
New +$266K 0.01% 1035
2020
Q1 		– Sell
-20,905
Closed -$1.8M – 1407
2019
Q4 		$1.77M Buy
+20,905
New +$1.58M 0.01% 779
2019
Q1 		– Sell
-4,154
Closed -$385K – 1844
2018
Q4 		$354K Sell
4,154
-6,443
-61% -$613K ﹤0.01% 1225
2018
Q3 		$1.03M Sell
10,597
-19,968
-65% -$1.99M 0.01% 1016
2018
Q2 		$2.88M Buy
30,565
+14,623
+92% +$1.28M 0.01% 719
2018
Q1 		$1.29M Buy
15,942
+12,698
+391% +$1.09M 0.01% 1111
2017
Q4 		$289K Buy
+3,244
New +$282K 0.01% 1025
2017
Q3 		– Sell
-10,786
Closed -$980K – 937
2017
Q2 		$980K Buy
+10,786
New +$981K 0.19% 96

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Securities's BMRN Position: Q1 2026 in Review

Two Sigma Securities opened a new position in BioMarin Pharmaceuticals (BMRN) in Q1 2026: 22,096 shares worth $1.25M. The stake represents 0.15% of the portfolio and ranks #166 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in BMRN as recently as Q2 2025.

Two Sigma Securities first reported a position in BMRN in Q2 2017 and has held it in 18 quarters since. The position peaked at $7.27M in Q3 2024. 555 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

  • Two Sigma Securities held 22,096 shares of BioMarin Pharmaceuticals worth $1.25M as of Q1 2026.
  • BioMarin Pharmaceuticals was a new Two Sigma Securities position in Q1 2026.
  • BioMarin Pharmaceuticals made up 0.15% of Two Sigma Securities's portfolio in Q1 2026, its #166 holding.
  • Two Sigma Securities first reported a position in BioMarin Pharmaceuticals in Q2 2017 and has held it in 18 quarters since.
  • Two Sigma Securities's BioMarin Pharmaceuticals position peaked at $7.27M in Q3 2024.
  • 555 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.